Alembic Pharma informs about press release

26 Dec 2017 Evaluate

Alembic Pharma has informed about press release announcing that the USFDA has granted Orphan-Drug Designation for Tenalisib (RP6530).

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

1003.25 1.40 (0.14%)
09-May-2024 15:44 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1493.35
Dr. Reddys Lab 5879.05
Cipla 1358.80
Zydus Lifesciences 967.80
Lupin 1585.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.